"Mycotoxin LFDs vs ELISA: What Actually Matters in Real Grain and Feed Testing?" is a practitioner-focused session presented by Martin Witek, Global Product Manager Mycotoxins, at Romer Labs. It is explicitly designed as a technical discussion, not a product promotion. The central argument is that the grain and feed industry continues to make mycotoxin screening method decisions based on format assumptions that do not hold up under scrutiny - and that a more evidence-based, decision-point-driven approach produces better operational outcomes.
Mycotoxin screening decisions affect every link in the grain and feed supply chain - from harvest intake to feed mill quality control, to central laboratory management and regulatory compliance. The method selection debate between lateral flow devices and ELISA is one that your audience navigates routinely, often with limited access to rigorous comparative evidence.
The session covers:
- Three persistent industry assumptions about ELISA superiority - and the evidence that challenges each
- A practical decision framework for matching method to matrix, workflow, and decision point
- The role of third-party verification and matrix-specific validation in evaluating any screening method
- Where each format genuinely excels - and where escalation to confirmatory analysis remains essential
Speaker: Martin Witek, Global Product Manager Mycotoxins, Romer Labs
Date & Time: Wednesday, 20 May 2026.
9:00 AM (New York)
10:00 AM (São Paulo)
3:00 PM (Berlin)
Register Now: Session 1
9:00 AM (Berlin)
3:00 PM (Singapore)
5:00 PM (Sydney)
Register Now: Session 2
